Who has invested in LOQUS23 THERAPEUTICS?

Forbion, SV Health Investors’ Dementia Discovery Fund, Novartis Venture Fund are named among the investors backing LOQUS23 THERAPEUTICS.

LOQUS23 THERAPEUTICS Funding: $43M Raised, Series A (2024)

LOQUS23 THERAPEUTICS funding overview

LOQUS23 THERAPEUTICS is a Biotech company based in Cambridge, United Kingdom. LOQUS23 THERAPEUTICS has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2024. The round record for LOQUS23 THERAPEUTICS runs through 2024; nothing later has been disclosed. Investors on record include Forbion, SV Health Investors’ Dementia Discovery Fund, Novartis Venture Fund. 3 distinct backers are named across the disclosed rounds.

LOQUS23 THERAPEUTICS at a glance

Total raised: $43M
Latest round: Series A
Latest round date: October 2024
Industry: Biotech
Headquarters: Cambridge, United Kingdom
Notable investors: Forbion, SV Health Investors’ Dementia Discovery Fund, Novartis Venture Fund

Frequently asked about LOQUS23 THERAPEUTICS funding

How much has LOQUS23 THERAPEUTICS raised?: LOQUS23 THERAPEUTICS has raised $43M in total disclosed funding across the rounds on record.
Who has invested in LOQUS23 THERAPEUTICS?: Forbion, SV Health Investors’ Dementia Discovery Fund, Novartis Venture Fund are named among the investors backing LOQUS23 THERAPEUTICS.
What was the latest LOQUS23 THERAPEUTICS funding round?: The most recent disclosed round is a Series A, announced in October 2024.
Where is LOQUS23 THERAPEUTICS based?: LOQUS23 THERAPEUTICS is based in Cambridge, United Kingdom.
What sector does LOQUS23 THERAPEUTICS operate in?: LOQUS23 THERAPEUTICS is tracked under Biotech from Cambridge, United Kingdom, with $43M in disclosed funding.
When did LOQUS23 THERAPEUTICS last raise?: The last disclosed LOQUS23 THERAPEUTICS round closed in October 2024 at Series A.

Round data for LOQUS23 THERAPEUTICS is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.

LOQUS23 THERAPEUTICS Funding: $43M Raised, Series A (2024)

LOQUS23 THERAPEUTICS funding overview

LOQUS23 THERAPEUTICS at a glance

Frequently asked about LOQUS23 THERAPEUTICS funding

LOQUS23 THERAPEUTICS founders (1)

Companies related to LOQUS23 THERAPEUTICS (40)

Browse related funding lists (7)